BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 12 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 2,540 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 2,540 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -33.3% | 2,540 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | 0.0% | 2,540 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -14.3% | 2,540 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | -30.0% | 2,540 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | +42.9% | 2,540 | 0.0% | 0.00% | – |
Q4 2020 | $7,000 | -95.0% | 2,540 | -29.6% | 0.00% | – |
Q3 2020 | $141,000 | +80.8% | 3,607 | +4.9% | 0.00% | – |
Q2 2020 | $78,000 | +188.9% | 3,440 | -1.0% | 0.00% | – |
Q1 2020 | $27,000 | +237.5% | 3,475 | +286.1% | 0.00% | – |
Q4 2019 | $8,000 | +60.0% | 900 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +25.0% | 900 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -20.0% | 900 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | -16.7% | 900 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | +20.0% | 900 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 359,000 | $1,712,000 | 0.28% |
BANK HAPOALIM BM | 24,926 | $119,000 | 0.04% |
Psagot Value Holdings Ltd. | 10,877 | $52,000 | 0.00% |
Mariner, LLC | 27,045 | $129,000 | 0.00% |
HighTower Advisors, LLC | 16,800 | $81,000 | 0.00% |
UBS Group AG | 2,992 | $14,000 | 0.00% |
ROYAL BANK OF CANADA | 900 | $4,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 874 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 470 | $2,000 | 0.00% |